News & Analysis as of

Food and Drug Administration (FDA) › Irreparable Harm

Kramer Levin Naftalis & Frankel LLP

Biosimilars in 2020: What’s Ahead

Kramer Levin Naftalis & Frankel LLP on

The Biologics Price Competition and Innovation Act of 2009 (BPCIA) was passed as part of health reform signed into law by President Obama in March 2010. This year, the BPCIA turns 10. While the U.S. Biosimilars Pathway has...more

King & Spalding

International Food Law Gazette - January 2016

King & Spalding on

FDA Approves First Genetically Modified Food-Producing Animal - On November 19, 2015, the United States Food and Drug Administration (FDA) approved a new animal drug application (NADA) that authorizes the marketing of...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide